MedPath

ADENOCARD - LIQ RAPID BOLUS IV 3MG/ML

ADENOCARD - LIQ RAPID BOLUS IV 3MG/ML

Discontinued
DIN Number

02139308

Drug Class

Human

Market Date

Aug 14, 1996

Company
HC

astellas pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02139308
AIG Number0113219001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB10 ADENOSINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification92:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ADENOSINEActive
Strength: 3 MG / ML
Monograph: ADENOSINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.